Physician profile
David A Gubin
NPI 1235164286
$1,034,636.59
in general payments reported to CMS, 2019-2025
59 companies · $2,179 in 2025
The $2,179 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,202 · 2021: $4,429 · 2022: $1.0M · 2023: $3,012 · 2024: $2,557 · 2025: $2,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,746.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Triad Life Sciences INC. | $1,003,804.79 | 2021-2022 | |
| Coloplast Corp | $18,792.98 | 2019-2025 | Titan, Speedicath, Virtue |
| Axonics, INC. | $2,179.68 | 2020-2024 | Axonics, Bulkamid |
| Teleflex LLC | $1,388.92 | 2021-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $1,016.27 | 2019-2025 | Solyx Sis System, Axonics |
| Sumitomo Pharma America, INC. | $952.29 | 2023-2025 | Orgovyx, Gemtesa |
| Medtronic, INC. | $656.52 | 2021-2025 | Interstim, Altaviva |
| Procept Biorobotics Corporation | $490.42 | 2019-2025 | Aquabeam Robotic System, Aquabeam System |
| Urogen Pharma, INC. | $423.24 | 2021-2025 | Jelmyto |
| Astellas Pharma US INC | $358.82 | 2019-2025 | Myrbetriq, Xtandi |
| Edap Technomed INC | $291.84 | 2022 | |
| Endo Pharmaceuticals INC. | $291.66 | 2019-2022 | |
| Myovant Sciences INC. | $282.58 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $250.85 | 2021-2024 | Prolaris |
| Medtronic USA, INC. | $244.06 | 2019-2020 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $226.54 | 2023-2025 | |
| Verity Pharmaceuticals INC. | $181.46 | 2022-2024 | Trelstar, Tlando |
| Pfizer INC. | $168.51 | 2019-2025 | |
| Angiodynamics, INC. | $150.41 | 2024 | Nanoknife |
| Srs Medical Systems, INC. | $145.64 | 2022 | |
| Biotissue Holdings INC. | $125.13 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $112.32 | 2021 | |
| Bard Access Systems, INC. | $105.74 | 2019 | |
| Abbvie INC. | $103.28 | 2020-2025 | |
| Cook Medical LLC | $101.13 | 2023 | Resonance |
| Accord Healthcare, INC. | $96.07 | 2024-2025 | |
| Karl Storz Endoscopy-America | $93.57 | 2021 | |
| Dendreon Pharmaceuticals LLC | $89.68 | 2020-2025 | Provenge |
| Janssen Biotech, INC. | $87.51 | 2021-2025 | Erleada, Akeega, Balversa |
| Photocure INC | $87.43 | 2021 | |
| Olympus America INC. | $79.94 | 2019-2025 | Soltive |
| Laborie Medical Technologies Corp. | $79.51 | 2020-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Neotract INC. | $79.17 | 2020 | |
| Ferring Pharmaceuticals INC. | $76.62 | 2019-2024 | Adstiladrin |
| C. R. Bard, INC. & Subsidiaries | $76.38 | 2021-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Sun Pharmaceutical Industries INC. | $75.13 | 2025 | |
| Progenics Pharmaceuticals, INC. | $72.98 | 2025 | |
| Endo USA, INC. | $67.36 | 2024-2025 | Xiaflex |
| Valencia Technologies Corporation | $66.87 | 2025 | Ecoin Device Kit |
| Agiliti Surgical, INC. | $54.86 | 2019-2023 | Sonablate, Trinity |
| Antares Pharma, INC. | $51.33 | 2019-2020 | |
| Tolmar, INC. | $51.12 | 2023-2025 | Jatenzo, Eligard |
| Tempus Ai, INC | $48.57 | 2024-2025 | Xt Cdx |
| Merck Sharp & Dohme LLC | $40.61 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $40.41 | 2024-2025 | |
| Clarus Therapeutics INC. | $40.38 | 2021 | |
| Travere Therapeutics, INC. | $39.56 | 2019-2021 | |
| Allergan, INC. | $37.95 | 2019-2022 | |
| Blue Earth Diagnostics | $37.16 | 2021 | |
| 180 Medical, INC. | $28.75 | 2023 | |
| Rochester Medical Corporation | $28.07 | 2019-2021 | |
| Urovant Sciences INC | $27.78 | 2022 | |
| Immunitybio, INC. | $24.84 | 2025 | |
| Integra Lifesciences Corporation | $24.68 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $24.21 | 2023 | Stravix |
| Pacira Pharmaceuticals Incorporated | $20.85 | 2024 | Exparel |
| Hollister Incorporated | $15.72 | 2022 | |
| Axogen | $14.39 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.